MLTX
MoonLake Immunotherapeutics
11.70$
+2.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1.4% | 99.5% | 99.6% | 97.7% | 99.2% | 99.4% | |
| 1.1% | 83.0% | 51.4% | 85.7% | 37.8% | 78.8% | |
| 1.1% | 83.0% | 93.8% | 97.1% | 93.7% | 92.8% | |
| – | 1.5% | 0.3% | 0.2% | 0.6% | 1.1% | |
| – | 13.7% | – | – | – | – | |
| – | 0.5% | 0.1% | – | – | – | |
| 3.6% | 220.3% | 10.5% | 2.5% | 5.1% | 28.3% | |
| 0.1% | 217.8% | 10.0% | 1.9% | 4.7% | 10.7% | |
| 0.0% | 154.9% | 0.2% | 0.2% | 0.3% | 0.3% | |
| – | 12.7% | 0.1% | 0.3% | 1.8% | 6.7% | |
| – | – | – | – | – | 17.5% | |
| 96.4% | -120.3% | 63.6% | 94.1% | 93.5% | 71.7% | |
| -2.2% | -554.0% | -105.0% | -22.2% | -49.3% | -109.1% | |
| 12.7% | 381.4% | 38.2% | 9.3% | 13.2% | 15.2% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.